In mice, CTLA-4 expression was evaluated in peripheral blood mononuclear cells (PBMCs), draining lymph nodes (LNs), and tumor-infiltrating lymphocytes (TILs) by flow cytometry 10 days after tumor challenge. Here, CTLA4 is linked to neoplasm.